Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling

McMullen, JR; Seymour, JF; Boey, EJ; Keating, MJ; Ooi, JY; Tam, CS
Abstract
Journal BLOOD
ISSN 0006-4971
Published 11 Dec 2014
Volume 124
Issue 25
Pages 3829-30
DOI 10.1182/blood-2014-10-604272
Type
Sponsorship